Australia's largest stock trading and investment forum Australia's #1 stock forum

Yep I want to see the long term data regarding the vaxcines -...

First 161 Last

Share
Profile

Follow
UniversalTrader

18,770 Posts.

56

10/05/24

09:25

Post #: 73756435
Share

Originally posted by zipperlip: ↑

You’re kinda correct, UT.

What the number of Upfront side effects is debatable, owing to the parameters considered pertinent by our Regulators but I guess we will never really know just what the proper number was.

Anyway, what is “Acceptable” in percentage terms?

As far as I’m concerned, you’re spot on about the Choice factor.

To this day when I talk to people about these novel treatments, I still make sure that I clarify my position that taking any treatment is up to the individual.

In regards to the potential for adverse outcomes owing to these treatments, I do like to point out that the experiment is Ongoing and that there are no guarantees that Adverse Effects are still possible going forward.

That doesn’t mean that I hope there is more adverse consequences to come just that there’s still potential.
Nor does it mean that I think everyone who took the experimental treatments will have adverse consequences.

I do however razz up those people who don’t believe that our government and health officials “overstepped” their job descriptions.

Expand

Yep I want to see the long term data regarding the vaxcines - that has always been my concern given the new nature of the ones used.
1 Upvote

Reply

Top Stories

EMD

Emyria's Empax Centre chosen for mental health clinical trial

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

FHE

Frontier Energy achieves key milestone for Waroona energy project

STX

Strike Energy secures $153 million for Perth Basin gas projects

BRX

Belararox delineates another porphyry in Argentina at Tambo South

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

There are more pages in this discussion • 9 more messages in this thread...

First 161 Last

SPONSORED BY